History news - Taiwan Leader in IVDs, Skincare, Zeaxanthin, Cancer Gene

Press Releases

全部

History news

VISGENEER INC. Taiwan Stock Exchange (symbol : 4197)

2021.07.23 China Times "Visgeneer Inc. operation up a notch ; leading the markets with Blue Ocean strategies."-more
2020.07.30 China Times A18- "Look forward to completion of Visgeneer Inc. Subsidiary"-more
2019.12.10 China Times C1- "Visgeneers goes across continents with Blue Ocean Strategy"-more
2019.12.05 China Times "Visgeneers expands strategy in Blue Ocean Market with new technology"-more
2019.05.29 OLLANTEIN "WINS THE GOLD QUALITY AWARD OF 2019"-more
2018.02.20 Bestadvisers.co.uk Review "the eBwell eB-W01 Blood Glucose Monitor shows the most accurate results."-more
2018.12.12, Our company has acquired the official letter with a certification number, 10701146230, from the Industrial Bureau of the Ministry of Economic Affairs and been approved the application of "Voluntary Cosmetic Good Manufacturing Practice Certificate".
2017.06.29 China Times -" Visgeneer Inc., running operation from bottom turned into uptrend in 2017, will apply for the listing of stock in 1st quarter, 2018."-more
2017.06.19 PharmaBoardRoom Interview - "Ken-Shwo Dai – President and CEO, Visgeneer, Taiwan"-more
2016.10.13 China Times A22-Industry Focus " Visgeneer Inc. Biotechnology filled with Innovations"-more
2016.05.26 China Times C5-Financial Management " Visgeneer Inc. the next shining Star "-more
2015.02.25 China Times C8-industry focus " Visgeneer Inc. product and production capacity to progress".-more
2015.02.15 Visgeneer Inc. is about to participate in the 2015 Italian Beauty Show 2015.03.20 ~ 23. Welcome to visit!
2015.01.30 "Economic Daily News Activity A19 " Visgeneer Inc.’s beam raising ceremony to mark the completion of the structural frames for the new plant. The plant will be completed Q2
2015.01.29 Commercial Times, Visgeneer Inc. beam raising ceremony, the new plant will be finished Q2.
2014.10.24 Visgeneer Inc. will participate in "2014 Germany Dusseldorf MEDICA International Medical Exhibition" from 2014.11.12 ~ 15. Welcome to come and visit our booth!
2014.10.24 Visgeneer Inc. will participate in "2014 COSMOPROF ASIA " from 2014.11.12 ~ 14. Welcome to come and visit our booth.-more
2014.7.22 Commercial Times, The groundbreaking ceremony for Visgeneer’s new plant will take place 7/19.
2014.7.22 Economic Daily News, Hsinchu City’s mayor has attended the groundbreaking ceremony for Visgeneer’s new plant.
2014.7.19 City News (Hsinchu City Government), Mayor Mr. Hsu has attended the groundbreaking ceremony for Visgeneer’s new plant on 7/19.
2014.6.24 Commercial Times, Blood glucose meter expert Visgeneer Inc. has broaden its field to health food.
2014.5.26 Commercial Times, Visgeneer’s production line is fully loaded and has purchased land to expend capacity.
2014.4.14 Commercial Times, Visgeneer’s allotment has reach target for two consecutive years
2014.3.30 Commercial Times, Visgeneer is operating great and will OTC this year.
2014.1.22 Commercial Times, Visgeneer is developing remote care to boost business.
2014.1.9 Commercial Times, Visgeneer is under good operation with great profit.
2013.11.21China Times, Visgeneer has expand interest to health care market.
2013.10.31China Times, Visgeneer Blood Glucose Monitoring System.
2013.10.24Visgeneer Inc. listed on taiwan otc stock market.
2013.5.27 Visgeneer Cosmetic factory has received ISO22716:2007 Cosmetics GMP Compliance certification from BUREAU VERITAS.
2012.06.14. The annual growth rate of Visgeneer’s blood glucose meter and test strip is 50%.
2012.02.07 Dr. Ken-Shwo Dai leads Visgeneer toward the broad road of the biotech industry.
2012.02.08 Germany patent NO 60 2006 021 742.0 ; Title: Human Ron-Related Gene Variant Associated with Cancers.
2011.02.01 Beijing Kang Da bai nian has become our sole distributor in China.
2010.12.09 Zeaxanthin from Visgeneer Inc. has been tested in US market.
2010.02.22 Vigenent Inc., a Wholly Owned Subsidiary of Visgeneer Inc., received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 0990143010)
2010.02.22 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09801039840)
2010.02.09 The investment plan in Hsinchu Biomedical Science Park proposed by Vigenent Inc., a Wholly Owned Subsidiary of Visgeneer Inc., has been approved by the National Science Council (NSC) of the Executive Yuan.
2010.02.01 An interview of Dr. Ken-Shwo Dai, president of Visgeneer Inc., was published in the 2010 February edition of Industrial Technology Research Institute entitled “Visgeneer Making Their Own Rules In Medical Device”
2009.11.23 Dr. Ken-Shwo Dai, President of Visgeneer Inc., received an interview from the Economic Daily News. The interview was published under the title of 「Using advanced technology to open Biotech market」.
2009.10.28The Company has been awarded the "Innovative R & D Award for Quality and Technology" at the Technical Department of the Ministry of Economic Affairs, and Chairman Dr. Dai was invited to share his success story..
2009.10.27 Visgeneer Inc. extraordinary shareholder’s meeting passed a resolution in setting up a wholly-owned subsidiary company.
2009.10.27 Dr Ken-Shwo Dai, President of Visgeneer Inc., received an interview from the Economic Daily News. The interview was published under the title of 「Visgeneer has an advantage in the cost on mass production of macular pigment」.
2009.09. 17 Visgeneer is granted with a ‘Small Business Innovation Research (SBIR) project entitled “The study of functional activity and optimum operating conditions for the macular pigment generated by a novel strain of Olleya marilimosa” by the Department of Industrial Technology, Ministry of Economic Affairs.
2009.09.04 Visgeneer Medical equipment product (Glucose meter & test strips) acquired Tender from India government.
2009.08.26 A collaborative research project entitled “Correlative analysis on the blood glucose and uric acid concentrations in diabetic patients” is established between Wei-Gong Memorial Hospital and Visgeneer Inc.
2009.08.19 Visgeneer Inc. has received a certification of "Emerging, Important, and Strategic Industries" from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09805024190 ).
2009.05.06 Obtained People's Republic of China Patent Certificate No. 1214002, utility model name: portable rechargeable talking biosensor.
2009.03.01 Visgeneer acquired an approval from Chunghwa Post Co., Ltd. to sell Coresence skin care series at their distribution channels.
2008.12.01 Received R.O.C patent NO. M346004; Title: A traveling biosensor with voice output and rechargeable function.
2008.08.08 Visgeneer purchases a factory and office building in responding to the requirement of increasing production lines.
2008.07.30 Visgeneer Inc. acquired an approval of adding new production items (CODE 09700612140) on the previous "Newly Emerging, Important, and Strategic Industries" (CODE 09600967610) certified by the Industrial Department Bureau, Ministry of Economic Affairs.
2008.07.28 We attended AACC Exhibition in Washington D.C, USA (7.28～08.01) and demonstrated Blood Glucose Monitoring System and 3 in 1 Remote Health Monitoring System.
2008.06.09 Taiwan Fertilizer, a listed company (1722), acquired a director and a supervisor of the board in the shareholder meeting of Visgeneer inc. in 2008.
2008.06.06 Economic Daily News: Revenue has increased in 2008.
2008.02.22 Visgeneer acquired blood glucose monitor approval from the State Food and Drug Administration of the PRC.
2008.01.23 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09600967610)
2007.11.26 Meeting of stockholders elected Taiwan Fertilizer Co., Ltd. as a Member of Board,Visgeneer Inc.
2007.11.14~17 Visgeneer Inc. participated in Dusseldorf, Germany's Medica 2007 Medical Devices Exhibition.
2007.05.17 Visgeneer Inc. has received a certification of "Emerging, Important, and Strategic Industries" from the Industrial Department Bureau, Ministry of Economic Affairs(NO 09605022930).
2007.03.02 Visgeneer eBsensor blood glucose factory is approved with Good Manufacturing Practice of Medical Device. (GMP Certification No. 0960302217)
2007.02.27 Institutional Review Board of Hsin Chu General Hospital, Department of Health has passed a resolution on 8/Feb/07 and signed a research collaboration contract with Visgeneer Inc. on 27/Feb/2007.
2007.01.15 Visgeneer has received CE Mark (CE0123) for the eBsensor Blood Glucose Monitoring System. certification from TUV PS.
2007.01.15 Visgeneer medical device factory has received ISO13485 : 2003.
2006.12.28 eBsensor Blood Glucose Monitoring System received US FDA 510K approval (No. K062555).
2006.12.15 Visgeneer Cosmetic factory has received ISO9001:2000 certification from TUV PS.
2006.12.11 Received ‘Small Business Innovation Research (SBIR) Subsidy Plan 2006’ entitled “A study of pathogenesis of T-cell lymphoblastic lymphoma” from the Industrial Department Bureau, Ministry of Economic Affairs.
2006.11.27 eBsensor Blood Glucose is approved with EN61010-1(2001) Standard.
2006.11.25 eBsensor Blood Glucose is approved with EN61326-1 Standard.
2006.10.23 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs. (NO 09500828690)
2006.9.21 The clinical study of eBsensor entitled "Clinical evaluation of the eBsensor hand-held blood glucose monitoring system" was accepted for publication in Clin Chim Acta
2006.8.15 eBsensor Blood Glucose is approved with EN60601-1(1990) +A1(1993) +A2(1995) +A13(1996) Standard.
2006.8.14 eBsensor Blood Glucose is approved with EN60601-1-2 : 2000 Standard.